Allergic rhinitis and its impact on asthma update (ARIA 2008) the Turkish perspective;Allerjik rinit ve astim üzerine etkisi güncelleme (ARIA 2008) Türkiye deneyimi

Tuberkuloz ve Toraks

Volumn 56, Issue 2, 2008, Pages 224-231

  Yorgancioǧlu, Arzu ^a   Kalayci, Ömer ^b   Kalyoncu, A Fuat ^b   Khaltaev, Nikolai ^c   Bousquet, Jean ^d  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Eriskin Allerji Ünitesi ^*  (France)

^d INSERM   (France)

Author keywords

Allergic rhinitis; ARIA; Asthma

Indexed keywords

ALLERGIC RHINITIS; ASTHMA; HEALTH CARE ORGANIZATION; REVIEW; TURKEY (BIRD);

ALLERGY AND IMMUNOLOGY; ASTHMA; HUMANS; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; RISK FACTORS; TURKEY;

EID: 47749094669     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007; 62 (Suppl 85): 17-25.
2. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: A systematic review. Allergy 2007; 62: 1359-71.
3. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007; 62 (Suppl 85): 9-16.
4. Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study. J Allergy Clin Immunol 2007; 120: 381-7.
5. Maurer M, Zuberbier T. Under treatment of rhinitis symptoms in Europe: Findings from a cross-sectional questionnaire survey. Allergy 2007; 62: 1057-63.
6. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007; 62: 216-23.
7. Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. 2007: 148.
8. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-43.
9. Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: The International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007; 62: 247-58.
10. Pekkarinen PT, von Hertzen L, Laatikainen T, et al. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy 2007; 62: 281-7.
11. Majkowska-Wojciechowska B, Pelka J, Korzon L, et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy 2007; 62: 1044-50.
12. Viinanen A, Munhbayarlah S, Zevgee T, et al. The protective effect of rural living against atopy in Mongolia. Allergy 2007; 62: 272-80.
13. van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: Linking immunology to accurate phenotype. Allergy 2007; 62: 237-46.
14. Kalyoncu AF, Selcuk ZT, Karakoca Y, et al. Prevalence of childhood asthma and allergic diseases in Ankara, Turkey. Allergy 1994; 49: 485-8.
15. Kucukoduk S, Aydin M, Cetinkaya F, et al. The prevalence of asthma and other allergic diseases in a province of Turkey. Turk J Pediatr 1996; 38: 149-53.
16. Selcuk ZT, Caglar T, Enunlu T, Topal T. The prevalence of allergic diseases in primary school children in Edirne, Turkey. Clin Exp Allergy 1997; 27: 262-9.
17. Karaman O, Turkmen M, Uzuner N. Allergic disease prevalence in Izmir. Allergy 1997; 52: 689-90.
18. Saraclar Y, Sekerel BE, Kalayci O, et al. Prevalence of asthma symptoms in school children in Ankara, Turkey. Respir Med 1998; 92: 203-7.
19. Celik G, Mungan D, Bavbek S, et al. The prevalence of allergic diseases and atopy in Ankara, Turkey: A two-step population-based epidemiological study. J Asthma 1999; 36: 281-90.
20. Akcakaya N, Kulak K, Hassanzadeh A, et al. Prevalence of bronchial asthma and allergic rhinitis in Istanbul school children. Eur J Epidemiol 2000; 16: 693-9.
21. Turktas I, Selcuk ZT, Kalyoncu AF. Prevalence of asthma-associated symptoms in Turkish children. Turk J Pediatr 2001; 43: 1-11.
22. Ece A, Ceylan A, Saraclar Y, et al. Prevalence of asthma and other allergic disorders among schoolchildren in Diyarbakir, Turkey. Turk J Pediatr 2001; 43: 286-92.
23. Saraclar Y, Kuyucu S, Tuncer A, et al. Prevalence of asthmatic phenotypes and bronchial hyperresponsiveness in Turkish schoolchildren: An International Study of Asthma and Allergies in Childhood (ISAAC) phase 2 study. Ann Allergy Asthma Immunol 2003; 91: 477-84.
24. Demir AU, Karakaya G, Bozkurt B, et al. Asthma and allergic diseases in schoolchildren: Third cross-sectional survey in the same primary school in Ankara, Turkey. Pediatr Allergy Immunol 2004; 15: 531-8.
25. Bayram I, Guneser-Kendirli S, Yilmaz M, et al. The prevalence of asthma and allergic diseases in children of school age in Adana in southern Turkey. Turk J Pediatr 2004; 46: 221-5.
26. Dinmezel S, Ogus C, Erengin H, et al. The prevalence of asthma, allergic rhinitis, and atopy in Antalya, Turkey. Allergy Asthma Proc 2005; 26: 403-9.
27. Demir E, Tanac R, Can D, et al. Is there an increase in the prevalence of allergic diseases among schoolchildren from the Aegean region of Turkey? Allergy Asthma Proc 2005; 26: 410-4.
28. Ones U, Akcay A, Tamay Z, et al. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006; 61: 1448-53.
29. Kurt E, Metintaş S, Başyiǧit İ, et al. Prevalence and risk factors of allergies in Turkey (PARFAIT Study): Results of a multicentric cross-sectional study in children. Pediatr Allergy Immunol 2007; 18: 566-574.
30. Kalyoncu AF, Demir AU, Ozcakar B, et al. Asthma and allergy in Turkish university students: Two cross-sectional surveys 5 years apart. Allergol Immunopathol (Madr) 2001; 29: 264-71.
31. Kuyucu S, Saraçlar Y, Tuncer A, et al. Epidemiologic characteristics of rhinitis in Turkish children: The International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol 2006; 17: 269-77.
32. Keleş N, Ilicali C. The impact of outdoor pollution on upper respiratory diseases. Rhinology 1998; 36: 24-7.
33. Keles N, Ilicali OC, Deger K. Impact of air pollution on prevalence of rhinitis in Istanbul. Arch Environ Health 1999; 54: 48-51.
34. Kalyoncu AF, Stalenheim G. Survey on the allergic status in a Turkish population in Sweden. Allergol Immunopathol (Madr) 1993; 21: 11-4.
35. Kabesch M, Schaal W, Nicolai T, von Mutius E. Lower prevalence of asthma and atopy in Turkish children living in Germany. Eur Respir J 1999; 13: 577-82.
36. Hjern A, Haglund B, Hedlin G. Ethnicity, childhood environment and atopic disorder. Clin Exp Allergy 2000; 30: 521-8.
37. Tobias A, Soriano JB, Chinn S, et al; European Community Respiratory Health Survey. Symptoms of asthma, bronchial responsiveness and atopy in immigrants and emigrants in Europe. European Community Respiratory Health Survey. Eur Respir J 2001; 18: 459-65.
38. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl): 147-334.
39. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: Developing guidelines. BMJ 1999; 318: 593-6.
40. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 2005; 60: 1112-5.
41. Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I-Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006; 117: 1054-62.
42. Bonini S, Bonini M, Bousquet J, et al. Rhinitis and asthma in athletes: An ARIA document in collaboration with GA2LEN. Allergy 2006; 6: 681-92.
43. Bousquet J, van Cauwenberge P, Ait Khaled N, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy 2006; 61: 1086-96.
44. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 2007; 119: 881-91.
45. Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007; 62 (Suppl 84): 1-41.
46. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24: 758-64.
47. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58: 672-5.
48. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006; 61: 693-8.
49. Todo-Bom A, Loureiro C, Almeida MM, et al. Epidemiology of rhinitis in Portugal: Evaluation of the intermittent and the persistent types. Allergy 2007; 62: 1038-43.
50. Van Hoecke H, Vastesaeger N, Dewulf L, et al. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol 2006; 118: 758-9.
51. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol 2007; 120: 359-65.
52. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62: 367-72.
53. Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: Longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007; 62: 378-84.
54. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the rhinoconjunctivitis quality of life questionnaire. Allergy 2007; 62: 1091-3.
55. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy 2007; 62: 1111-8.
56. Bonini M, Lapucci G, Petrelli G, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy 2007; 62: 1166-70.
57. Bonini S, Rasi G, Brusasco V, et al. Nonspecific provocation of target organs in allergic diseases: EAACIGA( 2)LEN consensus report. Allergy 2007; 62: 683-94.
58. Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study. J Allergy Clin Immunol 2007; 120: 863-9.
59. Chatkin MN, Menezes AM, Victora CG, Barros FC. High prevalence of asthma in preschool children in Southern Brazil: A population-based study. Pediatric Pulmonology 2003; 35: 296-301.
60. Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007; 62: 215-20.
61. Viegi G, La Grutta S. Rhinoconjunctivitis and wheeze in preschool children: A different relationship than in adults (United or Coexistent Airways Disease)? Allergy 2007; 62: 344-7.
62. Choi SH, Yoo Y, Yu J, et al. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy 2007; 62: 1051-6.
63. Bateman ED, Jithoo A. Asthma and allergy-a global perspective. Allergy 2007; 62: 213-5.
64. English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: Integrated guidelines for respiratory disease in developing countries. Allergy 2007; 62: 224-9.
65. Bousquet J, Khaltaev N, Cruz A, et al. ARIA Update. Allergy 2008; 63 (Suppl 86): 8-160.
66. Schunemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med 2007; 4: 119.
67. Brozek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy 2008; 63: 38-46.
68. Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007; 62: 1078-84.
69. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004; 20: 1549-58.
70. Barnes ML, Menzies D, Fardon TC, et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007; 62: 73-80.
71. Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy 2007; 62: 954-7.
72. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-9.
73. Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-40.
74. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-45.
75. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62: 317-24.
76. Clark J, Schall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy 2007; 62: 1023-8.
77. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2008; 121: 105-9.
78. Molgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007; 62: 1033-7.
79. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 2006; 118: 985-98.
80. Linneberg A, Jorgensen T, Nielsen NH, et al. The prevalence of skin-test-positive allergic rhinitis in Danish adults: Two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy 2000; 55: 767-72.
81. Terreehorst I, Oosting AJ, Tempels-Pavlica Z, et al. Prevalence and severity of allergic rhinitis in house dust miteallergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy 2002; 32: 1160-5.
82. Georgy V, Fahim HI, El Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur Respir J 2006; 28: 756-62.
83. Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007; 37: 954-60.
84. Antonicelli L, Micucci C, Voltolini S, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy 2007; 62: 1064-70.
85. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128: 3140-7.
86. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007; 62: 310-6.
87. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-8.
88. Civelek E, Soyer OU, Gemicioglu B, Sekerel BE. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy 2006; 61: 1454-8.
89. Demoly P, Concas V, Urbinelli R, Allaert F. Evaluation de l'influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enguête ERNANI. Rev fr Allergol Immunol Clin 2006; 46: 626-32.